LIN Today - Aug 10: Price Target Cut
Impossibile aggiungere al carrello
Puoi avere soltanto 50 titoli nel carrello per il checkout.
Riprova più tardi
Riprova più tardi
Rimozione dalla Lista desideri non riuscita.
Riprova più tardi
Non è stato possibile aggiungere il titolo alla Libreria
Per favore riprova
Non è stato possibile seguire il Podcast
Per favore riprova
Esecuzione del comando Non seguire più non riuscita
-
Letto da:
-
Di:
A proposito di questo titolo
So, what happened? Well, Linde started the day looking pretty steady but ended up getting a little pressure from some analysts. BMO Capital Markets decided to cut their price target for Linde, which kinda put a damper on things. You know how it is—when analysts start lowering their targets, it makes people a bit jittery.
Now, let’s talk about the why. BMO's reasoning was tied to some challenges they see in Linde's healthcare unit. They’re saying that the company’s facing some headwinds there, which is never a good sign. It’s like when you’re trying to enjoy a nice day out, and suddenly it starts raining. Nobody wants that! So, this news got folks a bit worried, and that’s why you saw some selling happening.
On the flip side, Goldman Sachs still has a buy rating on Linde, but they also made a small adjustment to their price target, dropping it from $585 to $580. It’s like a mixed bag of news—some good, some not so great.
One thing to keep in mind is that Linde’s been on a bit of a rollercoaster lately, so it’s worth keeping an eye on how this healthcare unit situation plays out. They’ve got some big expectations to meet, and investors are gonna be watching closely.
So, to wrap it up, Linde had a rough day mainly due to those analyst cuts, but there’s still some support out there from other firms. Just remember, this is all for info and entertainment, not financial advice. Catch you later!
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione